640 related articles for article (PubMed ID: 19340614)
1. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
2. New insight on a possible mechanism of progestogens in terms of breast cancer risk.
Neubauer H; Chen R; Schneck H; Knorrp T; Templin MF; Fehm T; Cahill MA; Seeger H; Yu Q; Mueck AO
Horm Mol Biol Clin Investig; 2011 Apr; 6(1):185-92. PubMed ID: 25961254
[TBL] [Abstract][Full Text] [Related]
3. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
4. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
[TBL] [Abstract][Full Text] [Related]
5. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
6. Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells.
Swiatek-De Lange M; Stampfl A; Hauck SM; Zischka H; Gloeckner CJ; Deeg CA; Ueffing M
Glia; 2007 Aug; 55(10):1061-73. PubMed ID: 17551930
[TBL] [Abstract][Full Text] [Related]
7. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
9. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
10. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
[TBL] [Abstract][Full Text] [Related]
11. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.
Ahmed IS; Rohe HJ; Twist KE; Mattingly MN; Craven RJ
J Pharmacol Exp Ther; 2010 May; 333(2):564-73. PubMed ID: 20164297
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
14. Dominant role of nuclear progesterone receptor in the control of rat periovulatory granulosa cell apoptosis.
Friberg PA; Larsson DG; Billig H
Biol Reprod; 2009 Jun; 80(6):1160-7. PubMed ID: 19208546
[TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.
Zhou J; Yu Q; Chen R; Seeger H; Fehm T; Cahill MA; Mueck AO; Neubauer H
Maturitas; 2013 Oct; 76(2):129-33. PubMed ID: 23856385
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
17. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
18. Possible role of PGRMC1 in breast cancer development.
Neubauer H; Ma Q; Zhou J; Yu Q; Ruan X; Seeger H; Fehm T; Mueck AO
Climacteric; 2013 Oct; 16(5):509-13. PubMed ID: 23758160
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
20. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
